BACKGROUND AND OBJECTIVES: Up to 95% of children presenting with steroid-resistant nephrotic syndrome in early life will have a pathogenic single-gene mutation in 1 of 24 genes currently associated with this disease. Others may be affected by polymorphic variants. There is currently no accepted diagnostic algorithm for clinical genetic testing. The hypothesis was that the increasing reliability of next generation sequencing allows comprehensive one-step genetic investigation of this group and similar patient groups. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study used next generation sequencing to screen 446 genes, including the 24 genes known to be associated with hereditary steroid-resistant nephrotic syndrome. The first 36 pediatric patients collected through a national United Kingdom Renal Registry were chosen with comprehensive phenotypic detail. Significant variants detected by next generation sequencing were confirmed by conventional Sanger sequencing. RESULTS: Analysis revealed known and novel disease-associated variations in expected genes such as NPHS1, NPHS2, and PLCe1 in 19% of patients. Phenotypically unexpected mutations were also detected in COQ2 and COL4A4 in two patients with isolated nephropathy and associated sensorineural deafness, respectively. The presence of an additional heterozygous polymorphism in WT1 in a patient with NPHS1 mutation was associated with earlier-onset disease, supporting modification of phenotype through genetic epistasis. CONCLUSIONS: This study shows that next generation sequencing analysis of pediatric steroid-resistant nephrotic syndrome patients is accurate and revealing. This analysis should be considered part of the routine genetic workup of diseases such as childhood steroid-resistant nephrotic syndrome, where the chance of genetic mutation is high but requires sequencing of multiple genes.
BACKGROUND AND OBJECTIVES: Up to 95% of children presenting with steroid-resistant nephrotic syndrome in early life will have a pathogenic single-gene mutation in 1 of 24 genes currently associated with this disease. Others may be affected by polymorphic variants. There is currently no accepted diagnostic algorithm for clinical genetic testing. The hypothesis was that the increasing reliability of next generation sequencing allows comprehensive one-step genetic investigation of this group and similar patient groups. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study used next generation sequencing to screen 446 genes, including the 24 genes known to be associated with hereditary steroid-resistant nephrotic syndrome. The first 36 pediatric patients collected through a national United Kingdom Renal Registry were chosen with comprehensive phenotypic detail. Significant variants detected by next generation sequencing were confirmed by conventional Sanger sequencing. RESULTS: Analysis revealed known and novel disease-associated variations in expected genes such as NPHS1, NPHS2, and PLCe1 in 19% of patients. Phenotypically unexpected mutations were also detected in COQ2 and COL4A4 in two patients with isolated nephropathy and associated sensorineural deafness, respectively. The presence of an additional heterozygous polymorphism in WT1 in a patient with NPHS1 mutation was associated with earlier-onset disease, supporting modification of phenotype through genetic epistasis. CONCLUSIONS: This study shows that next generation sequencing analysis of pediatric steroid-resistant nephrotic syndrome patients is accurate and revealing. This analysis should be considered part of the routine genetic workup of diseases such as childhood steroid-resistant nephrotic syndrome, where the chance of genetic mutation is high but requires sequencing of multiple genes.
Authors: Stephanie M Karle; Barbara Uetz; Vera Ronner; Lisa Glaeser; Friedhelm Hildebrandt; Arno Fuchshuber Journal: J Am Soc Nephrol Date: 2002-02 Impact factor: 10.121
Authors: J Marietta Clewing; Helen Fryssira; David Goodman; Sarah F Smithson; Emily A Sloan; Shu Lou; Yan Huang; Kunho Choi; Thomas Lücke; Harika Alpay; Jean-Luc André; Yumi Asakura; Nathalie Biebuyck-Gouge; Radovan Bogdanovic; Dominique Bonneau; Caterina Cancrini; Pierre Cochat; Sandra Cockfield; Laure Collard; Isabel Cordeiro; Valerie Cormier-Daire; Karlien Cransberg; Karel Cutka; Georges Deschenes; Jochen H H Ehrich; Stefan Fründ; Helen Georgaki; Encarna Guillen-Navarro; Barbara Hinkelmann; Maria Kanariou; Belde Kasap; Sara Sebnem Kilic; Guiliana Lama; Petra Lamfers; Chantal Loirat; Silvia Majore; David Milford; Denis Morin; Nihal Ozdemir; Bertram F Pontz; Willem Proesmans; Stavroula Psoni; Herbert Reichenbach; Silke Reif; Cristina Rusu; Jorge M Saraiva; Onur Sakallioglu; Beate Schmidt; Lawrence Shoemaker; Sabine Sigaudy; Graham Smith; Flora Sotsiou; Natasa Stajic; Anja Stein; Asbjørg Stray-Pedersen; Doris Taha; Sophie Taque; Jane Tizard; Michel Tsimaratos; Newton A C S Wong; Cornelius F Boerkoel Journal: Hum Mutat Date: 2007-03 Impact factor: 4.878
Authors: Marije Löwik; Elena Levtchenko; Dineke Westra; Patricia Groenen; Eric Steenbergen; Jan Weening; Marc Lilien; Leo Monnens; Lambert van den Heuvel Journal: Nephrol Dial Transplant Date: 2008-04-28 Impact factor: 5.992
Authors: Marco Seri; Alessandro Pecci; Filomena Di Bari; Roberto Cusano; Maria Savino; Emanuele Panza; Alessandra Nigro; Patrizia Noris; Simone Gangarossa; Bianca Rocca; Paolo Gresele; Nicola Bizzaro; Paola Malatesta; Pasi A Koivisto; Ilaria Longo; Roberto Musso; Carmine Pecoraro; Achille Iolascon; Umberto Magrini; Juan Rodriguez Soriano; Alessandra Renieri; Gian Marco Ghiggeri; Roberto Ravazzolo; Carlo L Balduini; Anna Savoia Journal: Medicine (Baltimore) Date: 2003-05 Impact factor: 1.889
Authors: Agnieszka Bińczak-Kuleta; Jacek Rubik; Mieczysław Litwin; Małgorzata Ryder; Klaudyna Lewandowska; Olga Taryma-Leśniak; Jeremy S Clark; Ryszard Grenda; Andrzej Ciechanowicz Journal: Bosn J Basic Med Sci Date: 2014-05 Impact factor: 3.363
Authors: Heon Yung Gee; Shazia Ashraf; Xiaoyang Wan; Virginia Vega-Warner; Julian Esteve-Rudd; Svjetlana Lovric; Humphrey Fang; Toby W Hurd; Carolin E Sadowski; Susan J Allen; Edgar A Otto; Emine Korkmaz; Joseph Washburn; Shawn Levy; David S Williams; Sevcan A Bakkaloglu; Anna Zolotnitskaya; Fatih Ozaltin; Weibin Zhou; Friedhelm Hildebrandt Journal: Am J Hum Genet Date: 2014-05-08 Impact factor: 11.025
Authors: Maija Suvanto; Jaakko Patrakka; Timo Jahnukainen; Pia-Maria Sjöström; Matti Nuutinen; Pekka Arikoski; Janne Kataja; Marjo Kestilä; Hannu Jalanko Journal: Clin Exp Nephrol Date: 2016-08-29 Impact factor: 2.801